Literature DB >> 12916138

Psychosocial predictors of hepatitis B vaccination among young African-American gay men in the deep south.

Scott D Rhodes1, Ralph J Diclemente.   

Abstract

BACKGROUND: Despite recommendations for vaccination against hepatitis B virus (HBV) of men who have sex with men (MSM), most remain unvaccinated. GOAL: The goal of this study was to identify attitudes and beliefs associated with vaccination against HBV among black MSM. STUDY
DESIGN: The Birmingham Vaccine Acceptance Questionnaire was used to collect data from gay bar patrons.
RESULTS: Of the 143 participants, nearly 42% reported at least one dose of HBV vaccine. In multivariable analysis, characteristics associated with vaccination were a decreased perception of barriers to HBV vaccination (odds ratio [OR], 0.37; 95% confidence interval [CI], 0.22-0.61; P = 0.001); increased perceived medical severity (OR, 5.34; 95% CI, 2.38-11.96; P = 0.001) and personal severity (OR, 2.22; 95% CI, 1.38-3.56; P = 0.006) of HBV infection; and increased perceived general medical self-efficacy (OR, 9.22; 95% CI, 3.52-24.11; P = 0.0001) and personal self-efficacy (OR, 2.3; 95% CI, 1.14-4.63; P = 0.008) to complete the three-dose series.
CONCLUSIONS: Our findings underscore the need to increase vaccination through innovative approaches to reduce perceived barriers to vaccination while increasing perceived severity of HBV infection and self-efficacy to complete the vaccine series.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12916138     DOI: 10.1097/00007435-200305000-00013

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  8 in total

1.  Trends in Prevalence of Protective Levels of Hepatitis B Surface Antibody Among Adults Aged 18-49 Years With Risk Factors for Hepatitis B Virus Infection-United States, 2003-2014.

Authors:  Hope King; Jian Xing; Hazel D Dean; Deborah Holtzman
Journal:  Clin Infect Dis       Date:  2020-04-15       Impact factor: 9.079

2.  Nursing case management, peer coaching, and hepatitis a and B vaccine completion among homeless men recently released on parole: randomized clinical trial.

Authors:  Adeline Nyamathi; Benissa E Salem; Sheldon Zhang; David Farabee; Betsy Hall; Farinaz Khalilifard; Barbara Leake
Journal:  Nurs Res       Date:  2015 May-Jun       Impact factor: 2.381

3.  Risk factors for liver disease and associated knowledge and practices among Mexican adults in the US and Mexico.

Authors:  Yvonne N Flores; Cathy M Lang; Jorge Salmerón; Roshan Bastani
Journal:  J Community Health       Date:  2012-04

4.  Predictors of HAV/HBV vaccination completion among methadone maintenance clients.

Authors:  Adeline Nyamathi; Karabi Sinha; Barbara Greengold; Allan Cohen; Mary Marfisee
Journal:  Res Nurs Health       Date:  2010-04       Impact factor: 2.228

5.  Hepatitis B vaccination among a national sample of gay and bisexual men.

Authors:  Paul L Reiter; Noel T Brewer
Journal:  Sex Transm Dis       Date:  2011-03       Impact factor: 2.830

6.  HIV and sexually transmitted disease risk among male Hispanic/Latino migrant farmworkers in the Southeast: Findings from a pilot CBPR study.

Authors:  Scott D Rhodes; Werner E Bischoff; Jacqueline M Burnell; Lara E Whalley; Michael P Walkup; Quirina M Vallejos; Sara A Quandt; Joseph G Grzywacz; Haiying Chen; Thomas A Arcury
Journal:  Am J Ind Med       Date:  2010-10       Impact factor: 2.214

7.  Long-term effect of mobile phone-based education and influencing factors of willingness to receive HPV vaccination among female freshmen in Shanxi Province, China.

Authors:  Liying Sun; Jingjing Hu; Huihui Gao; Sunyi Wang; Binghan Wang; Jiawen Wang; Hui Li; Jianbing Wang; Changzheng Yuan; Xi Zhang
Journal:  Hum Vaccin Immunother       Date:  2022-04-21       Impact factor: 4.526

8.  Hepatitis vaccination of men who have sex with men at gay pride events.

Authors:  Erik David Storholm; Dennis G Fisher; Grace L Reynolds; Lucy E Napper; Timothy A Morrisse; Lee M Kochems
Journal:  Prev Sci       Date:  2010-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.